Al-Dawaa Medical Services Company

SASE:4163 Stock Report

Market Cap: ر.س6.7b

Al-Dawaa Medical Services Future Growth

Future criteria checks 3/6

Al-Dawaa Medical Services is forecast to grow earnings and revenue by 14.1% and 6.8% per annum respectively. EPS is expected to grow by 12.1% per annum. Return on equity is forecast to be 30.3% in 3 years.

Key information

14.1%

Earnings growth rate

12.1%

EPS growth rate

Consumer Retailing earnings growth19.7%
Revenue growth rate6.8%
Future return on equity30.3%
Analyst coverage

Good

Last updated09 Dec 2024

Recent future growth updates

Al-Dawaa Medical Services Company (TADAWUL:4163) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 14
Al-Dawaa Medical Services Company (TADAWUL:4163) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Recent updates

Al-Dawaa Medical Services Company (TADAWUL:4163) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 14
Al-Dawaa Medical Services Company (TADAWUL:4163) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Benign Growth For Al-Dawaa Medical Services Company (TADAWUL:4163) Underpins Its Share Price

Sep 24
Benign Growth For Al-Dawaa Medical Services Company (TADAWUL:4163) Underpins Its Share Price

The Returns At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Growing

Jul 29
The Returns At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Growing

Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)

Jun 03
Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)

Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality

May 08
Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality

Al-Dawaa Medical Services (TADAWUL:4163) Hasn't Managed To Accelerate Its Returns

Apr 05
Al-Dawaa Medical Services (TADAWUL:4163) Hasn't Managed To Accelerate Its Returns

Al-Dawaa Medical Services (TADAWUL:4163) Has Some Way To Go To Become A Multi-Bagger

Dec 26
Al-Dawaa Medical Services (TADAWUL:4163) Has Some Way To Go To Become A Multi-Bagger

Al-Dawaa Medical Services (TADAWUL:4163) Has Announced A Dividend Of SAR1.25

Sep 03
Al-Dawaa Medical Services (TADAWUL:4163) Has Announced A Dividend Of SAR1.25

Return Trends At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Appealing

Jul 13
Return Trends At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Appealing

Is Al-Dawaa Medical Services Company (TADAWUL:4163) Expensive For A Reason? A Look At Its Intrinsic Value

Jun 22
Is Al-Dawaa Medical Services Company (TADAWUL:4163) Expensive For A Reason? A Look At Its Intrinsic Value

Returns On Capital Signal Tricky Times Ahead For Al-Dawaa Medical Services (TADAWUL:4163)

Apr 10
Returns On Capital Signal Tricky Times Ahead For Al-Dawaa Medical Services (TADAWUL:4163)

Some Shareholders Feeling Restless Over Al-Dawaa Medical Services Company's (TADAWUL:4163) P/E Ratio

Mar 14
Some Shareholders Feeling Restless Over Al-Dawaa Medical Services Company's (TADAWUL:4163) P/E Ratio

Is Al-Dawaa Medical Services Company (TADAWUL:4163) Trading At A 34% Discount?

Dec 08
Is Al-Dawaa Medical Services Company (TADAWUL:4163) Trading At A 34% Discount?

Earnings and Revenue Growth Forecasts

SASE:4163 - Analysts future estimates and past financials data (SAR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20267,1995005088225
12/31/20256,7224394297496
12/31/20246,2983686109094
9/30/20246,187359405666N/A
6/30/20246,000355474703N/A
3/31/20245,850348597836N/A
12/31/20235,741329502726N/A
9/30/20235,742326704848N/A
6/30/20235,612303716881N/A
3/31/20235,485295529743N/A
12/31/20225,372305528778N/A
9/30/20225,212285266651N/A
6/30/20225,163275142519N/A
3/31/20225,119247217561N/A
12/31/20215,034239361670N/A
9/30/20214,977254413649N/A
6/30/20214,958300400644N/A
3/31/20214,932286348566N/A
12/31/20204,962246166378N/A
12/31/20193,962233356515N/A
12/31/20183,797228244392N/A
12/31/20173,376121N/A568N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4163's forecast earnings growth (14.1% per year) is below the savings rate (14.7%).

Earnings vs Market: 4163's earnings (14.1% per year) are forecast to grow faster than the SA market (6% per year).

High Growth Earnings: 4163's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4163's revenue (6.8% per year) is forecast to grow faster than the SA market (-0.5% per year).

High Growth Revenue: 4163's revenue (6.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 4163's Return on Equity is forecast to be high in 3 years time (30.3%)


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 16:56
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Al-Dawaa Medical Services Company is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Duaa AlFaddaBofA Global Research
Alia El MehelmyCI Capital Research
Michel SalamehCitigroup Inc